Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Uncoupling the dopamine D1-D2 receptor complex: a novel target for antidepressant treatment.

Wong AH, Liu F.

Clin Pharmacol Ther. 2012 Feb;91(2):298-302. doi: 10.1038/clpt.2011.311. Epub 2011 Dec 28.

PMID:
22205193
2.

Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.

Shuto T, Seeman P, Kuroiwa M, Nishi A.

Eur J Neurosci. 2008 May;27(10):2551-7. doi: 10.1111/j.1460-9568.2008.06221.x. Epub 2008 May 16.

PMID:
18489579
3.

Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.

Haraguchi K, Ito K, Kotaki H, Sawada Y, Iga T.

Drug Metab Dispos. 1997 Jun;25(6):675-84.

4.

Involvement of D1 and D2 dopamine receptors in the antidepressant-like effects of selegiline in maternal separation model of mouse.

Amiri S, Amini-Khoei H, Mohammadi-Asl A, Alijanpour S, Haj-Mirzaian A, Rahimi-Balaei M, Razmi A, Olson CO, Rastegar M, Mehdizadeh M, Zarrindast MR.

Physiol Behav. 2016 Sep 1;163:107-114. doi: 10.1016/j.physbeh.2016.04.052. Epub 2016 Apr 30.

PMID:
27143252
5.

Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.

Cyr M, Morissette M, Barden N, Beaulieu S, Rochford J, Di Paolo T.

Neuroscience. 2001;102(1):151-8.

PMID:
11226678
6.

Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors.

Perachon S, Schwartz JC, Sokoloff P.

Eur J Pharmacol. 1999 Feb 5;366(2-3):293-300.

PMID:
10082211
7.

Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization--a working hypothesis.

Dziedzicka-Wasylewska M, Faron-Górecka A, Górecki A, Kuśemider M.

Pharmacol Rep. 2008 Sep-Oct;60(5):581-7. Review.

8.
9.

Emerging drugs for major depressive disorder.

Kennedy SH, Rizvi SJ.

Expert Opin Emerg Drugs. 2009 Sep;14(3):439-53. doi: 10.1517/14728210903107751. Review.

PMID:
19637989
10.

Dopamine is involved in the antidepressant-like effect of allopregnanolone in the forced swimming test in female rats.

D'Aquila PS, Canu S, Sardella M, Spanu C, Serra G, Franconi F.

Behav Pharmacol. 2010 Feb;21(1):21-8. doi: 10.1097/FBP.0b013e32833470a7.

PMID:
20009921
11.
12.

First enantioselective syntheses of the dopamine D1 and D2 receptor modulators, (+)- and (-)-govadine.

Zhai H, Miller J, Sammis G.

Bioorg Med Chem Lett. 2012 Feb 15;22(4):1557-9. doi: 10.1016/j.bmcl.2012.01.005. Epub 2012 Jan 10.

PMID:
22284818
13.

Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.

Engber TM, Marin C, Susel Z, Chase TN.

Eur J Pharmacol. 1993 Jun 4;236(3):385-93.

PMID:
8102970
14.
15.

[Efficacy of atypical antipsychotics in depressive syndromes].

Quintin P, Thomas P.

Encephale. 2004 Nov-Dec;30(6):583-9. Review. French.

PMID:
15738862
16.

Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat.

Ainsworth K, Smith SE, Zetterström TS, Pei Q, Franklin M, Sharp T.

Psychopharmacology (Berl). 1998 Dec;140(4):470-7.

PMID:
9888623
17.

Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.

Cepeda C, André VM, Yamazaki I, Wu N, Kleiman-Weiner M, Levine MS.

Eur J Neurosci. 2008 Feb;27(3):671-82. doi: 10.1111/j.1460-9568.2008.06038.x.

PMID:
18279319
18.

Functional interaction between dopamine D1 and D2 receptors in 'MPTP' monkeys.

Luquin MR, Guillén J, Martínez-Vila E, Laguna J, Martínez-Lage JM.

Eur J Pharmacol. 1994 Mar 3;253(3):215-24.

PMID:
7911084
19.

WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: a novel dopamine D2 receptor partial agonist/serotonin reuptake inhibitor with preclinical antipsychotic-like and antidepressant-like activity.

Brennan JA, Graf R, Grauer SM, Navarra RL, Pulicicchio CM, Hughes ZA, Lin Q, Wantuch C, Rosenzweig-Lipson S, Pruthi F, Lai M, Smith D, Goutier W, van de Neut M, Robichaud AJ, Rotella D, Feenstra RW, Kruse C, Broqua P, Beyer CE, McCreary AC, Pausch MH, Marquis KL.

J Pharmacol Exp Ther. 2010 Jan;332(1):190-201. doi: 10.1124/jpet.109.157388. Epub 2009 Oct 14.

20.

Supplemental Content

Support Center